A phase 3, double-blind, randomized placebo-controlled efficacy and safety study of abiraterone acetate in chemotherapy-naïve patients with mCRPC in China, Malaysia, Thailand and Russia

Authors:

Abstract
No abstract available
Funding Information
  • Janssen Research & Development, LLC

This publication has 12 references indexed in Scilit: